W2414214441
Y. Ko, Birgit C. P. Koch, Volker Harth et al. · Pharmacogenetics · 2000
Ko, Y.; Koch, B.; Harth, V.; Sachinidis, A.; Thier, R.; Vetter, H.; Bolt, H. M.; Brüning, T. Author Information
Cited by 61 works. doi:10.1097/00008571-200004000-00009
Authors
- Y. Ko
- Birgit C. P. Koch
- Volker Harth
- Agapios Sachinidis
- Ricarda Thier
- Hans Vetter
- Hermann M. Bolt
- Thomas Brüning
References
- The Glut athione S-Transferase Supergene Family: Regulation of GST and the Contribution of the lsoenzymes to Cancer Chemoprotection and Drug Resistance Part I
- Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism
- Genetic Risk and Carcinogen Exposure: a Common Inherited Defect of the Carcinogen-Metabolism Gene Glutathione S-Transferase M1 (GSTM1) That Increases Susceptibility to Bladder Cancer
- Identification of genetic polymorphisms at the glutathione S- transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer
- Genetic Polymorphisms of Human N -Acetyltransferase, Cytochrome P450, Glutathione-S-Transferase, and Epoxide Hydrolase Enzymes: Relevance to Xenobiotic Metabolism and Toxicity
- Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks
- Polymorphism of the Pi class glutathione S-transferase in normal populations and cancer patients
- A rare CYP19 (aromatase) variant may increase the risk of breast cancer
- Genetic Polymorphisms in Human Drug Metabolic Enzymes,
- Detection of the GSTM1*0 allele by long polymerase chain reaction